Registry for thoracic disease specimens

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry aims to collect and store specimens from patients with thoracic diseases, including lung cancer and lung transplants, to support research on their causes, early diagnosis, and treatment. The specimens will include blood, bronchoalveolar lavage fluid, pleural fluid, and tissue samples. Managed by the Mayo Clinic Thoracic Specimen Registry Steering Committee, this initiative will facilitate the development of new research protocols and clinical trials to improve patient outcomes in thoracic diseases.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Subject must be \> 18 years of age
* Presumed or known or screening of Thoracic Diseases (which includes but not limited to the following: thoracic neoplasms (masses/nodules) malignant or benign, interstitial lung diseases (ILD), chronic obstructive pulmonary disease (COPD), thoracic infections, thoracic malignancies metastatic to other organs, other cancers metastatic to the thoracic cavity.

Where it's running

• Mayo Clinic in Rochester
  Rochester, Minnesota, United States Recruiting

Study contacts

• Principal investigator: Eric Edell, MD — Mayo Clinic
• Study coordinator: Aaron Bungum
• Email: Bungum.Aaron@mayo.edu
• Phone: 507-266-0078

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Research on improving outcomes for lung transplant donors and recipients

  This study is trying to see how different donor and medical practices affect the health of lung transplant patients and donors, while also looking for blood markers that might predict complications after the surgery.

  Recruiting at 19 sites Duke University · Los Angeles, California and 18 other locations · NCT06399302

• Registry for double lung transplants in patients with lung-limited cancers

  This study is collecting information on patients with lung-limited cancers who are getting double lung transplants to see how well the procedure works for them.

  Recruiting Northwestern University · Chicago, Illinois · NCT05671887

• ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden

  This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.

  Recruiting Tongji Hospital · Hubei, Wuhan · NCT07912190

• Urine VOC Test to Detect Lung Cancer in Never Smokers

  A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.

  Recruiting Thomas Jefferson University · Philadelphia, Pennsylvania · NCT07871656

• Multidisciplinary non-drug program to improve quality of life after solid organ transplant

  A multidisciplinary, non-drug program using acupuncture, remote physical rehab, and brain-health activities is being tested to see if it can improve quality of life for adults at least one year after heart, kidney, liver, or lung transplant.

  Recruiting The Mediterranean Institute for Transplantation and Advanced Specialized Therapies · Palermo, Palermo · NCT07870811

• SI-B036 safety test in advanced and metastatic solid tumors

  This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.

  Recruiting at 4 sites Phase 1 SystImmune Inc. · New Haven, Connecticut and 6 other locations · NCT07857616

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.